https://researchpepnews.com/articles/retatrutide-greatest-drug-ever-viral-claim-audit Research Pep News en 2026-08-04 Is Retatrutide Really “the Greatest Drug Ever”? A Viral-Claim Audit https://researchpepnews.com/images/editorial/retatrutide-greatest-drug-ever-viral-claim-audit.png Retatrutide’s ‘greatest drug ever’ label is viral rhetoric. Its triple-receptor design and 28.3% average weight-loss result in TRIUMPH-1 are documented clinical findings. Graphic: Research Pep News. https://researchpepnews.com/articles/kpv-ulcerative-colitis-gut-inflammation Research Pep News en 2026-08-04 KPV for Ulcerative Colitis and Gut Inflammation: Promising Signal or Peptide Anecdote? https://researchpepnews.com/images/editorial/kpv-ulcerative-colitis-gut-inflammation.jpg Persistent gastrointestinal symptoms can reflect active inflammation, residual injury, infection or a different diagnosis; KPV research is most meaningful when the target is defined. Photo by cottonbro studio/Pexels. https://researchpepnews.com/articles/bpc157-tb500-wolverine-stack-injury-recovery Research Pep News en 2026-08-04 BPC-157 and TB-500 for Injury Recovery: Did the ‘Wolverine Stack’ Help—or Was It Time and Rehab? https://researchpepnews.com/images/editorial/wolverine-stack-injury-recovery-rehab.jpg A physiotherapist assists a client during a rehabilitation exercise in Vilnius, Lithuania. Recovery stories involving BPC-157 and TB-500 often include structured physical therapy at the same time. Photo by Funkcinės Terapijos Centras via Pexels.